$VTVT
vTv Therapeutics Inc.

2021 Q2 Form 10-Q Financial Statement

#000156459021040889 Filed on August 04, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $9.000K $0.00
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.242M $1.700M
YoY Change 31.88% -28.87%
% of Gross Profit
Research & Development $2.437M $2.510M
YoY Change -2.91% -40.63%
% of Gross Profit
Depreciation & Amortization $25.00K $20.00K
YoY Change 25.0% 100.0%
% of Gross Profit
Operating Expenses $4.679M $4.200M
YoY Change 11.4% -36.56%
Operating Profit -$4.670M
YoY Change
Interest Expense $0.00 $222.0K
YoY Change -100.0% -56.81%
% of Operating Profit
Other Income/Expense, Net $2.898M -$570.0K
YoY Change -608.42% -57100.0%
Pretax Income -$841.0K -$4.991M
YoY Change -83.15% -0.46%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$608.0K -$3.368M
YoY Change -81.95% 16.86%
Net Earnings / Revenue -6755.56%
Basic Earnings Per Share
Diluted Earnings Per Share -$10.37K -$73.81K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.84M $6.400M
YoY Change 69.3% 326.67%
Cash & Equivalents $10.80M $6.392M
Short-Term Investments
Other Short-Term Assets $437.0K $400.0K
YoY Change 9.25% -20.0%
Inventory
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.27M $6.800M
YoY Change 65.76% 79.14%
LONG-TERM ASSETS
Property, Plant & Equipment $322.0K $412.0K
YoY Change -21.84% 662.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $9.622M $2.500M
YoY Change 284.88% 0.0%
Other Assets $400.0K
YoY Change -84.62%
Total Long-Term Assets $10.39M $3.800M
YoY Change 173.37% -27.98%
TOTAL ASSETS
Total Short-Term Assets $11.27M $6.800M
Total Long-Term Assets $10.39M $3.800M
Total Assets $21.66M $10.60M
YoY Change 104.34% 16.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.855M $6.700M
YoY Change -27.54% -19.28%
Accrued Expenses $169.0K $100.0K
YoY Change 69.0% -50.0%
Deferred Revenue $35.00K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $4.500M
YoY Change -100.0% -47.67%
Total Short-Term Liabilities $5.059M $11.40M
YoY Change -55.62% -33.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $50.00K $5.400M
YoY Change -99.07% 1976.92%
Total Long-Term Liabilities $50.00K $5.400M
YoY Change -99.07% 1976.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.059M $11.40M
Total Long-Term Liabilities $50.00K $5.400M
Total Liabilities $9.293M $80.20M
YoY Change -88.41% 265.98%
SHAREHOLDERS EQUITY
Retained Earnings -$273.1M
YoY Change
Common Stock $224.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$47.82M -$69.53M
YoY Change
Total Liabilities & Shareholders Equity $21.66M $10.60M
YoY Change 104.34% 16.84%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$608.0K -$3.368M
YoY Change -81.95% 16.86%
Depreciation, Depletion And Amortization $25.00K $20.00K
YoY Change 25.0% 100.0%
Cash From Operating Activities -$3.997M -$4.790M
YoY Change -16.56% -12.91%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.385M 8.280M
YoY Change -22.89% 314.0%
NET CHANGE
Cash From Operating Activities -3.997M -4.790M
Cash From Investing Activities
Cash From Financing Activities 6.385M 8.280M
Net Change In Cash 2.388M 3.490M
YoY Change -31.58% -199.71%
FREE CASH FLOW
Cash From Operating Activities -$3.997M -$4.790M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q2 us-gaap Assets
Assets
21660000
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
313000
CY2021Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
124000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
11272000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
322000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
444000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
9622000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
6725000
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4855000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
169000
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
84000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5059000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
50000
CY2021Q2 us-gaap Liabilities
Liabilities
9293000
CY2021Q2 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
60190000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
224457000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-273114000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-47823000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21660000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
587000
CY2021Q2 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
3588000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-841000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4991000
CY2020Q2 us-gaap Interest Expense
InterestExpense
222000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
888000
us-gaap Interest Expense
InterestExpense
390000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6768000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12156000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-841000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-4991000
us-gaap Profit Loss
ProfitLoss
-6783000
us-gaap Profit Loss
ProfitLoss
-12156000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-233000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1623000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1934000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4064000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-608000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3368000
us-gaap Net Income Loss
NetIncomeLoss
-4849000
us-gaap Net Income Loss
NetIncomeLoss
-8092000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-608000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3368000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4849000
CY2021Q2 vtvt Issuance Of Class A Common Stock Under Atm Offering
IssuanceOfClassACommonStockUnderATMOffering
5335000
CY2021Q2 vtvt Issuance Of Class A Common Stock Under Lpc Agreement
IssuanceOfClassACommonStockUnderLPCAgreement
1049000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-3368000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
186000
CY2020Q2 vtvt Issuance Of Class A Common Stock Under Atm Offering
IssuanceOfClassACommonStockUnderATMOffering
7280000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-80102000
us-gaap Net Income Loss
NetIncomeLoss
-4849000
vtvt Issuance Of Class A Common Stock Under Atm Offering
IssuanceOfClassACommonStockUnderATMOffering
5335000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
47000
vtvt Issuance Of Class A Common Stock Under Lpc Agreement
IssuanceOfClassACommonStockUnderLPCAgreement
9087000
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
21771000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-47823000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-49023000
us-gaap Net Income Loss
NetIncomeLoss
-8092000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
566000
vtvt Issuance Of Class A Common Stock Under Atm Offering
IssuanceOfClassACommonStockUnderATMOffering
7280000
vtvt Stock Issued During Period Value Conversion Of Convertible Securities Related Party
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty
7000000
us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-27259000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-69528000
us-gaap Profit Loss
ProfitLoss
-6783000
us-gaap Profit Loss
ProfitLoss
-12156000
us-gaap Depreciation
Depreciation
45000
us-gaap Depreciation
Depreciation
49000
us-gaap Share Based Compensation
ShareBasedCompensation
888000
us-gaap Share Based Compensation
ShareBasedCompensation
566000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2897000
vtvt Change In Fair Value Of Warrants Related Party
ChangeInFairValueOfWarrantsRelatedParty
717000
vtvt Change In Fair Value Of Warrants Related Party
ChangeInFairValueOfWarrantsRelatedParty
928000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
182000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-158000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-873000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-670000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-384000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
84000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1811000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14385000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
12469000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5088000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2115000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5747000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4277000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-273100000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10800000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, the Company evaluates its estimates, including those related to the grant date fair value of equity awards, the fair value of warrants to purchase shares of its Class A Common Stock, the fair value of the Class B Common Stock, the useful lives of property and equipment, the fair value of derivative liabilities, and the fair value of the Company’s debt, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions. The balances of these cash accounts frequently exceed insured limits.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">One customer represented 100% of the revenue earned during the three months and six months ended June 30, 2021.  Revenue for the three and six months ended June 30, 2020 was insignificant.</p>
CY2021Q2 vtvt Adjustments To Transaction Price For Performance Obligations
AdjustmentsToTransactionPriceForPerformanceObligations
0
CY2020Q2 vtvt Adjustments To Transaction Price For Performance Obligations
AdjustmentsToTransactionPriceForPerformanceObligations
0
vtvt Adjustments To Transaction Price For Performance Obligations
AdjustmentsToTransactionPriceForPerformanceObligations
0
vtvt Adjustments To Transaction Price For Performance Obligations
AdjustmentsToTransactionPriceForPerformanceObligations
0
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
31000
CY2021Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
9000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1009000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1040000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
500000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4453357
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.41
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
70000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.56
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
20833
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
28121
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4474403
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2148776
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
4256790
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P7Y6M
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
452000
CY2021Q2 vtvt Investment Ownership Percentage
InvestmentOwnershipPercentage
0.20
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.131
CY2021Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
9623000
CY2020Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
6725000
CY2021Q2 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.215
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.131
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y7M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M6D
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
128000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
261000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
268000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
275000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
23000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
955000
CY2021Q2 vtvt Operating Leases Imputed Interest
OperatingLeasesImputedInterest
199000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
756000
CY2021Q2 vtvt Redeemable Noncontrolling Interest Temporary Equity Redemption Value
RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue
60200000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-608000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3368000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4849000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8092000
CY2021Q2 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
115000
CY2020Q2 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
3006000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
2525000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
5429000
CY2021Q2 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-723000
CY2020Q2 us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-6374000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-7374000
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
-13521000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29582766
CY2020Q4 vtvt Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
250000000
CY2021Q2 vtvt Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
350000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
29601117
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-841000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-4991000
us-gaap Profit Loss
ProfitLoss
-6783000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-233000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1623000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1934000
CY2021Q2 vtvt Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-608000

Files In Submission

Name View Source Status
0001564590-21-040889-index-headers.html Edgar Link pending
0001564590-21-040889-index.html Edgar Link pending
0001564590-21-040889.txt Edgar Link pending
0001564590-21-040889-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gh1fkhql5pxz000001.jpg Edgar Link pending
gh1fkhql5pxz000002.jpg Edgar Link pending
gh1fkhql5pxz000003.jpg Edgar Link pending
gh1fkhql5pxz000004.jpg Edgar Link pending
gh1fkhql5pxz000005.jpg Edgar Link pending
gh1fkhql5pxz000006.jpg Edgar Link pending
gh1fkhql5pxz000007.jpg Edgar Link pending
gh1fkhql5pxz000008.jpg Edgar Link pending
gh1fkhql5pxz000009.jpg Edgar Link pending
gh1fkhql5pxz000010.jpg Edgar Link pending
gh1fkhql5pxz000011.jpg Edgar Link pending
gh1fkhql5pxz000012.jpg Edgar Link pending
gh1fkhql5pxz000013.jpg Edgar Link pending
gh1fkhql5pxz000014.jpg Edgar Link pending
gh1fkhql5pxz000015.jpg Edgar Link pending
gh1fkhql5pxz000016.jpg Edgar Link pending
gh1fkhql5pxz000017.jpg Edgar Link pending
gh1fkhql5pxz000018.jpg Edgar Link pending
gh1fkhql5pxz000019.jpg Edgar Link pending
gh1fkhql5pxz000020.jpg Edgar Link pending
gh1fkhql5pxz000021.jpg Edgar Link pending
gh1fkhql5pxz000022.jpg Edgar Link pending
gh1fkhql5pxz000023.jpg Edgar Link pending
gh1fkhql5pxz000024.jpg Edgar Link pending
gh1fkhql5pxz000025.jpg Edgar Link pending
gh1fkhql5pxz000026.jpg Edgar Link pending
gh1fkhql5pxz000027.jpg Edgar Link pending
gh1fkhql5pxz000028.jpg Edgar Link pending
gh1fkhql5pxz000029.jpg Edgar Link pending
gh1fkhql5pxz000030.jpg Edgar Link pending
gh1fkhql5pxz000031.jpg Edgar Link pending
gh1fkhql5pxz000032.jpg Edgar Link pending
gh1fkhql5pxz000033.jpg Edgar Link pending
gh1fkhql5pxz000034.jpg Edgar Link pending
gh1fkhql5pxz000035.jpg Edgar Link pending
gh1fkhql5pxz000036.jpg Edgar Link pending
gh1fkhql5pxz000037.jpg Edgar Link pending
gh1fkhql5pxz000038.jpg Edgar Link pending
gh1fkhql5pxz000039.jpg Edgar Link pending
gh1fkhql5pxz000040.jpg Edgar Link pending
gh1fkhql5pxz000041.jpg Edgar Link pending
gh1fkhql5pxz000042.jpg Edgar Link pending
gh1fkhql5pxz000043.jpg Edgar Link pending
gh1fkhql5pxz000044.jpg Edgar Link pending
gybmclm2lu4a000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtvt-10q_20210630.htm Edgar Link pending
vtvt-10q_20210630_htm.xml Edgar Link completed
vtvt-20210630.xsd Edgar Link pending
vtvt-20210630_cal.xml Edgar Link unprocessable
vtvt-20210630_def.xml Edgar Link unprocessable
vtvt-20210630_lab.xml Edgar Link unprocessable
vtvt-20210630_pre.xml Edgar Link unprocessable
vtvt-ex101_200.htm Edgar Link pending
vtvt-ex311_6.htm Edgar Link pending
vtvt-ex312_7.htm Edgar Link pending
vtvt-ex31_201.htm Edgar Link pending
vtvt-ex321_8.htm Edgar Link pending
vtvt-ex322_9.htm Edgar Link pending